Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Ascelia Pharma

3.00 SEK

-1.96 %

Less than 1K followers

ACE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Ascelia Pharma

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)16.3339.0220.6510.342.332.923.22
Shares33.641.448.950.450.497.2126.9
Market cap549.21,615.61,008.8521.0117.5283.8407.9
Enterprise value440.71,431.8747.8371.996.7233.9-
EV/S-------
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B2.326.843.282.881.583.604.10
P/S-------
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio94.7 %92.4 %92.3 %82.7 %85.4 %56.0 %88.9 %
Gearing ratio-0.4 %0.2 %0.3 %1.4 %32.2 %1.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.